Hereditary Cancer Genetic Testing

Hereditary Cancer Genetic Testing is a specialized medical test that analyzes an individual’s DNA to identify inherited genetic mutations linked to an increased risk of developing certain cancers. Unlike standard cancer tests, this test focuses on detecting changes passed down through families that can predispose a person to cancers such as breast, ovarian, colorectal, and prostate cancer. By identifying these mutations early, individuals and healthcare providers can implement personalized prevention, monitoring, and treatment strategies. This testing helps guide decisions about risk-reducing measures and informs family members about their potential cancer risks, enabling proactive health management.

Why Choose This Hereditary Cancer Genetic Testing?

Choosing Hereditary Cancer Genetic Testing empowers individuals with vital information about their genetic risk for certain cancers. This knowledge enables proactive health decisions, such as enhanced screening, lifestyle changes, or preventive treatments, potentially reducing the chances of cancer development or catching it early when treatment is more effective. It also provides valuable insights for family members who might share the same genetic risk, allowing them to take preventive measures. Ultimately, this testing offers peace of mind by clarifying cancer risk and supporting personalized care plans tailored to one’s unique genetic profile.

When Is It Used?

A strong family history of certain cancers like breast, ovarian, colorectal, or prostate cancer.
Personal history of cancer diagnosed at a young age.
Multiple family members diagnosed with the same or related types of cancer.
A known genetic mutation has been identified in a close relative.
Cancer diagnosis in multiple generations of a family.
Rare or aggressive cancer types that may have a hereditary component.
To guide treatment options for someone already diagnosed with cancer.

Who Should Consider Hereditary Cancer Genetic Testing?

Hereditary Cancer Genetic Testing is recommended for individuals who have a personal or family history suggesting an increased risk of inherited cancers. Those who have close relatives diagnosed with cancer at a young age or multiple family members affected by related cancers should consider this testing. It is also advised for people whose cancer type is commonly linked to genetic mutations or when a known mutation exists in the family. This testing helps identify genetic risks early, allowing individuals to make informed decisions about prevention, screening, and treatment strategies tailored to their genetic profile.

You should consider this test if:

Individuals with a strong family history of breast, ovarian, colorectal, or other hereditary cancers
People diagnosed with cancer at a young age (typically before 50)
Those with multiple family members affected by the same or related cancers
Individuals from families with known genetic mutations linked to cancer
People with rare or aggressive cancer types
Those planning preventive measures or early screening based on genetic risk
Individuals seeking personalized treatment options after a cancer diagnosis

How We Work

How is the Test Performed?

Our Services

Just a few of the many health issues we screen for

BRCA1 Mutation

A genetic change increasing breast and ovarian cancer risk, often leading to earlier onset and aggressive tumor development in affected individuals.

BRCA2 Mutation

Inherited mutation linked to higher risk of breast, ovarian, pancreatic, and prostate cancers, often prompting enhanced screening and preventive measures.

PALB2 Mutation

Inherited mutation that raises breast cancer risk and may influence pancreatic cancer development, important for personalized risk management strategies.

CDH1 Mutation

Hereditary mutation increasing risk of diffuse gastric cancer and lobular breast cancer, often requiring proactive screening and surgical consideration.

NBN Mutation

Inherited genetic change associated with increased breast cancer risk and possibly other cancers due to defective DNA repair mechanisms.

MSH2 Mutation

Inherited mutation causing defective DNA repair, leading to Lynch syndrome and heightened risk of various cancers, especially colorectal and endometrial.

Who we Are

Why Choose Us?

State-of-the-Art Digital Lab Experience

Our fully integrated E-Lab platform offers online test ordering, real-time tracking, and secure digital reporting bringing convenience and control to both physicians and patients across the country.

Advanced Diagnostic Technology

From routine blood tests to complex genetic panels, we leverage cutting-edge platforms like NGS, PCR, and AI-powered analytics for maximum accuracy and clinical relevance.

Fast Turnaround, Local Support

With lab facilities based in Florida, we ensure faster processing times and direct access to our expert team. You get timely results backed by responsive, local customer support.

Get your free estimate!

Comprehensive Thyroid Panel
Comprehensive Thyroid Panel
Food Sensitivity & Allergy Testing (IgG/IgE Panels)
STI/STD Comprehensive Panel (PCR or Blood Tests)
Diabetes Panel (HbA1c, Fasting Glucose, Insulin, C-Peptide)
Autoimmune Disease Panel

Comprehensive Thyroid Panel
Comprehensive Thyroid Panel
Food Sensitivity & Allergy Testing (IgG/IgE Panels)
STI/STD Comprehensive Panel (PCR or Blood Tests)
Diabetes Panel (HbA1c, Fasting Glucose, Insulin, C-Peptide)
Autoimmune Disease Panel

TESTS

NGS TESTING

PCR TESTING

Infectious Disease